| The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 4946 | 2013 |
| Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ... Cell 164 (3), 550-563, 2016 | 1996 | 2016 |
| The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 DH Gutmann, A Aylsworth, JC Carey, B Korf, J Marks, RE Pyeritz, ... Jama 278 (1), 51-57, 1997 | 1651 | 1997 |
| The role of microglia and macrophages in glioma maintenance and progression D Hambardzumyan, DH Gutmann, H Kettenmann Nature neuroscience 19 (1), 20-27, 2016 | 1396 | 2016 |
| Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis K Yamanaka, SJ Chun, S Boillee, N Fujimori-Tonou, H Yamashita, ... Nature neuroscience 11 (3), 251-253, 2008 | 1305 | 2008 |
| Subtypes of medulloblastoma have distinct developmental origins P Gibson, Y Tong, G Robinson, MC Thompson, DS Currle, C Eden, ... Nature 468 (7327), 1095-1099, 2010 | 928 | 2010 |
| Comprehensive and integrated genomic characterization of adult soft tissue sarcomas AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ... Cell 171 (4), 950-965, 2017 | 806 | 2017 |
| Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients TN Basu, DH Gutmann, JA Fletcher, TW Glover, FS Collins, J Downward Nature 356 (6371), 713-715, 1992 | 806 | 1992 |
| Neurofibromatosis type 1 revisited VC Williams, J Lucas, MA Babcock, DH Gutmann, B Korf, BL Maria Pediatrics 123 (1), 124-133, 2009 | 796 | 2009 |
| Neurofibromatosis type 1 DH Gutmann, RE Ferner, RH Listernick, BR Korf, PL Wolters, KJ Johnson Nature Reviews Disease Primers 3 (1), 1-17, 2017 | 770 | 2017 |
| International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis RE Ferner, DH Gutmann Cancer research 62 (5), 1573-1577, 2002 | 766 | 2002 |
| Challenges to curing primary brain tumours K Aldape, KM Brindle, L Chesler, R Chopra, A Gajjar, MR Gilbert, ... Nature reviews Clinical oncology 16 (8), 509-520, 2019 | 680 | 2019 |
| The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 H Morrison, LS Sherman, J Legg, F Banine, C Isacke, CA Haipek, ... Genes & development 15 (8), 968-980, 2001 | 671 | 2001 |
| Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex LH Zeng, L Xu, DH Gutmann, M Wong Annals of Neurology: Official Journal of the American Neurological …, 2008 | 662 | 2008 |
| Optic pathway gliomas in neurofibromatosis‐1: controversies and recommendations R Listernick, RE Ferner, GT Liu, DH Gutmann Annals of Neurology: Official Journal of the American Neurological …, 2007 | 642 | 2007 |
| Neurofibromatosis type 1: a multidisciplinary approach to care AC Hirbe, DH Gutmann The Lancet Neurology 13 (8), 834-843, 2014 | 602 | 2014 |
| Neurofibromatosis 1 JM Friedman | 571 | 2022 |
| Microglia states and nomenclature: A field at its crossroads RC Paolicelli, A Sierra, B Stevens, ME Tremblay, A Aguzzi, B Ajami, I Amit, ... Neuron 110 (21), 3458-3483, 2022 | 569 | 2022 |
| Cellular and molecular identity of tumor-associated macrophages in glioblastoma Z Chen, X Feng, CJ Herting, VA Garcia, K Nie, WW Pong, R Rasmussen, ... Cancer research 77 (9), 2266-2278, 2017 | 558 | 2017 |
| Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force R Listernick, DN Louis, RJ Packer, DH Gutmann Annals of Neurology: Official Journal of the American Neurological …, 1997 | 554 | 1997 |
Arie PerryProfessor and Director of Neuropathology, UCSFEmail confirmado em ucsf.edu
